Mable (Neurolytic Healthcare)
About:
Genomics based individualized care for people with neurological conditions.
Website: https://www.trymable.com/
Top Investors: Y Combinator, Creative Destruction Lab (CDL), Initialized Capital, Illumina, Fast Track Malmo
Description:
Neurolytic Healthcare provides personalized medicine for neurological conditions. Neurolytic Healthcare collects and extracts insights from a combination of genetic and biomarker data to enhance diagnosis and help clinicians decide on optimal treatment strategies for neurological conditions. The company delivers digitally and genomically-driven medical devices to improve the current treatment of migraine and other neurological disorders, including a diagnostic support tool, pharmacogenetic test, and a mobile app for migraine event prediction.
$3.25M
$1M to $10M
Oxford, Oxfordshire, United Kingdom
2019-01-01
r.roth(AT)trymable.com
Inna Nicole Thalmann, Roman Rothaermel
11-50
2022-07-27
Private
© 2025 bioDAO.ai